North America's Expanding Role in Anti-PD-1 Monoclonal...

adicionou um novo artigo Health

2026-09-21 09:26:30

North America's Expanding Role in Anti-PD-1 Monoclonal Antibody Research

The Anti-PD-1 MAb Market in North America is witnessing steady growth as immune checkpoint inhibitors gain increasing adoption in cancer treatment. Anti-PD-1 monoclonal antibodies (MAbs) block the programmed cell death protein 1 (PD-1) pathway, helping enhance T-cell activity against cancer cells. Market Overview The anti-PD-1 mAb market stood at US$ 75.85 Million in 2025 and is forecast to...

0 Comentários 0 Compartilhamentos 101 Visualizações 0 Anterior